So why is Dynavax stock trading at less than twice Heplisav - B's
peak sales potential?
Though peak sales of the drug vary and the marketplace Syndros is entering is exceptionally crowded, it could very well have
peak sales potential of around $ 300 million, meaning an eventual replacement of Subsys» lost sales.
Blueprint Medicines (BPMC)- The current $ 3.75 billion valuation compares favorably to $ 2 billion
peak sales potential of two lead drug candidates, while their solid cash position after the December secondary offering and their deep pipeline provide adequate cushion to the current share price.
Not exact matches
«Copanlisib may have a greater success and
potential than we initially anticipated,» Bryan Garnier analysts said, adding they would revise their current
peak sales estimate of 600 million euros ($ 666 million).
In Figure 1, we break down an estimate of the
peak annual
sales revenues for a hypothetical biotech drug in a competitive market with a
potential market size of 1 million patients, an estimated
sales price of $ 20,000 per year and a royalty rate of 10 %.
According to FierceBiotech, Spinraza has
peak annual
sales potential of $ 2.5 billion.
The biotech's various clinical assets in non-alcoholic steatohepatitis and anti-inflammatory drug candidate filgotinib both have the
potential to generate several billion in
sales at
peak.
«After analyzing multiple options, we concluded that MyCheck was a unique partner that could meet our needs, given their
potential to not only boost the guest experience that our customers have come to expect at our venues, but also increase
sales and help our staff reach
peak performance.
And the fact Saga now trades on 3.2 times
peak earnings is a great reminder of the
potential upside if we see
sales regain / surpass their previous FY - 2013
peak in due course.